Introduction phorylated Sohda et al., 1998) , and when this occurs, p115 can no longer bind (NakaThe Golgi apparatus of mammalian cells has a distincmura et al. , 1997) . This is believed to prevent docking tive morphology during interphase, comprising a ribbon of COPI vesicles and so explains the inhibition of transof stacked flattened cisternae with cis-and trans-Golgi port and the COPI-mediated fragmentation of Golgi cisnetworks on either face of the stack (Rambourg and ternae in mitosis. Clermont, 1990) . In mitosis, this organization is dramatiPassage through the eukaryotic cell cycle requires cally altered. The Golgi ribbon is first broken up into the successive activation of different cyclin-dependent many individual stacks that then fragment further, yieldkinases (CDKs) (reviewed by Nigg, 1995) . The transition ing clusters of vesicles and tubules (Misteli and Warren, from G2 to M phase is controlled by Cdc2, which forms 1995a). Mitotic Golgi fragmentation has been extencomplexes with cyclins of the A and B families. Cdk2, which is predominantly active at the G1-S transition and sively studied morphologically in vivo and can be mimin S phase, appears also to play a role in regulating icked in a cell-free system by incubating purified Golgi entry into mitosis, since it can act as a positive regumembranes with cytosol prepared from mitotic HeLa lator of cyclin B-Cdc2 (Guadagno and Newport, 1996) . cells . This has led to the Cdc2 is responsible for many of the cellular reorganizadefinition of two principal fragmentation pathways. The tions that take place at the onset of mitosis, such as COPI-mediated pathway likely consumes the cisternal chromosome condensation, disassembly of the nuclear rims, giving rise to numerous COPI-coated vesicles lamina, and formation of a mitotic spindle (Nigg, 1995) . . This pathway accounts for Studies on Golgi fragmentation showed that this proabout two-thirds of cisternal membrane. The remaining cess is also dependent upon Cdc2 (Misteli and Warren, Golgi membrane is consumed by the less-well charac-1994) . Similarly, activation of Cdc2 but not Cdk2 was terized COPI-independent pathway, which appears to shown to inhibit transport between Golgi cisternae Stuart et al., 1993) . However, § To whom correspondence should be addressed.
whether Cdc2 was acting directly or via a downstream have led to the suggestion that Cdc2 does not directly . In a separate experiment, incubations were performed with mockdepleted cytosol (lane 6), Cdc2-depleted cytosol (lane 7), or Cdc2-depleted cytosol supplemented with purified recombinant cyclin B1-Cdc2 added to the same histone kinase activity as the mock-depleted sample (lane 8). N73pep was analyzed by SDS-PAGE and autoradiography (top). GM130 was immunoprecipitated from solubilized Golgi membranes before SDS-PAGE and autoradiography (bottom). . In a separate experiment, incubations were performed with mitotic cytosol (lane 6) or cyclin B2-Cdc2 (lane 7). The amounts of kinase were normalized for their activity against histone H1. Proteins were analyzed by SDS-PAGE and autoradiography. (D) Phosphorylation of GM130 on Golgi membranes with purified recombinant kinases. Salt-washed Golgi membranes were incubated in the presence of [␥- 32 P]ATP with either buffer alone (lane 1), mitotic cytosol (lane 2), purified cyclin E-cdk2 (lane 3), or cyclin B1-Cdc2 (lane 4). Equivalent levels of histone kinase activity were used in each case. After solubilization of the membranes, GM130 was immunoprecipitated and detected by autoradiography. (E) Phosphopeptide mapping of GM130. GM130 was immunoprecipitated from 32 P-labeled mitotic NRK cells (left) or from salt-washed Golgi membranes phosphorylated in vitro using cyclin B1-Cdc2 in the presence of [␥- 32 P]ATP (middle). N73pep was phosphorylated in vitro using mitotic cytosol and [␥-32 P]ATP (right). After SDS-PAGE and tryptic digestion, phosphopeptides were separated in two dimensions by electrophoresis followed by chromatography and detected by autoradiography. The origin is at the bottom left corner. The major phosphopeptide is labeled with the letter "a" and the minor ones with "b" and "c." participate in Golgi fragmentation, but rather acts through First, the specific CDK inhibitor olomuocine prevented GM130 phosphorylation in vitro . MEK1, a component of the MAP kinase signaling pathway (Acharya et al., 1998) . It was proposed that MEK1 Second, removal of CDKs from mitotic cytosol using p13 suc1 beads abolished GM130 phosphorylation (data phosphorylates and activates a putative novel ERK on Golgi membranes, which then phosphorylates Golginot shown). To identify the GM130 kinase, we took advantage of these findings and used specific antibodies specific targets to bring about disassembly in mitosis. In this paper, we now show that GM130 can be directly to deplete the two CDKs known to play a role in the initiation and progression of mitosis, Cdc2 and Cdk2, phosphorylated by Cdc2 kinase. Furthermore, we provide evidence that Cdc2 activity is essential for mitotic from mitotic cytosol. The efficiency of depletion was shown by immunoblotting to be greater than 95% (FigGolgi fragmentation, while MEK1 is not essential for this process either in vitro or in vivo. ure 1A, top). Depletion of Cdc2 removed more than 90% of the histone kinase activity ( Figure 1A, bottom) . The depleted cytosols were tested for their ability to phosResults phorylate a synthetic peptide corresponding to the N-terminal 73 amino acids of GM130 (N73pep). This peptide GM130 Is Phosphorylated by Cdc2 Kinase Two lines of evidence suggested that a CDK was recontains the p115-binding site and is efficiently phosphorylated by mitotic cytosol in vitro (Nakamura et al., sponsible for the mitotic phosphorylation of GM130. 1997). Depletion of Cdk2 had no effect upon phosphorylation of the GM130 peptide ( Figure 1B , top, lane 3), while phosphorylation was almost completely abolished by depletion of Cdc2 ( Figure 1B , top, lane 4). The kinasedepleted cytosols were also tested for their ability to phosphorylate native GM130 on Golgi membranes. Native GM130 was phosphorylated to a similar extent by Cdk2-depleted, mock-depleted, and untreated mitotic cytosol ( Figure 1B , bottom, lanes 2, 3, and 5), while very little phosphorylation was observed with the Cdc2-depleted cytosol ( Figure 1B , bottom, lane 4). Phosphory- mitotic cytosol, purified cyclin A-Cdk2, cyclin E-Cdk2, cyclin B1-Cdc2, or cyclin B2-Cdc2. The amounts of did not bind (lanes 2, 3, and 5). In contrast, GM130 kinase added were normalized using histone H1 as a treated with Cdc2-depleted cytosol bound efficiently to substrate. Cdc2 complexed to either cyclin B1 or B2 the p115 beads (lane 4). This strongly suggests that phosphorylated the GM130 peptide at a similar rate (not Cdc2-mediated phosphorylation of GM130 regulates shown) and to a similar level as mitotic cytosol ( washed Golgi membranes with purified CDKs and anaIn contrast, there was no significant phosphorylation lyzing the ability of GM130 to bind p115. As shown in of the peptide by Cdk2, irrespective of whether it was Figure 2 , treatment with mitotic cytosol or cyclin B1-complexed to cyclin E or A ( Figure 1C, lanes 3 and 4) . The Cdc2 inhibited binding to p115 (lanes 7 and 9), while ability of the purified kinases to phosphorylate native cyclin E-Cdk2 had no effect (lane 8). Similar results were GM130 on Golgi membranes was also tested. As shown obtained with in vitro-synthesized recombinant GM130 in Figure 1D , GM130 was phosphorylated by cyclin B1-(not shown). Cdc2 (lane 4) to a level comparable to mitotic cytosol (lane 2) but not by cyclin E-Cdk2 (lane 3).
GM130 Is Phosphorylated on Serine 25
If Cdc2 is the mitotic GM130 kinase, it should phosThe consensus motif for Cdc2 is Ser/Thr-Pro-X-Arg/Lys, phorylate GM130 at the same sites in vitro as those with Pro at the ϩ1 position absolutely critical, and a phosphorylated in mitotic cells. To investigate this, basic residue at the ϩ3 position preferred but not essen-GM130 was immunoprecipitated from 32 P-labeled mitial for kinase recognition (Songyang et al., 1994; Holmes totic NRK cells and subjected to two-dimensional tryptic and Solomon, 1996) . There are three Ser and no Thr phosphopeptide mapping. The resulting pattern revealed residues with Pro at the ϩ1 position, all close to the N one major phosphopeptide (spot a) and two poorly reterminus of rat GM130, the region we previously identisolved minor phosphopeptides (spots b and c) ( Figure  fied as the p115-binding site ( Figure 3A ). Phospho-1E, left). When GM130 was immunoprecipitated from amino acid analysis of mitotically phosphorylated GM130 Golgi membranes phosphorylated in vitro with purified showed that it is phosphorylated exclusively on Ser resicyclin B1-Cdc2, a very similar pattern was obtained dues (data not shown). Since N73pep was efficiently ( Figure 1E , middle). This strongly suggests that GM130 phosphorylated by mitotic cytosol in vitro, we reasoned is phosphorylated at the same sites by Cdc2 in vitro that the major phosphorylation site of GM130 would lie as those phosphorylated in vivo, consistent with Cdc2 in this region, which has two SP motifs. To determine phosphorylating GM130 in mitotic cells.
if this was the case, N73pep was phosphorylated using mitotic cytosol and subjected to two-dimensional tryptic phosphopeptide mapping. This gave rise to one major Phosphorylation of GM130 by Cdc2 Inhibits Binding to p115 phosphopeptide (spot a) at the same position as the major phosphopeptide of the full-length GM130 protein We have previously shown that mitotic phosphorylation of GM130 prevents binding to the vesicle-docking pro-( Figure 1E ; compare right with left panel), confirming that the major mitotic phosphorylation site of GM130 tein p115 . To determine whether the Cdc2-mediated phosphorylation of GM130 can acresides within this peptide sequence. To identify the modified residue, N73pep was phosphorylated by micount for this regulation, salt-washed Golgi membranes were phosphorylated in vitro using the CDK-depleted totic cytosol, proteolytically digested, and mass spectrometry performed on the proteolytic fragments. The mitotic cytosols, the membranes were solubilized, and binding of GM130 to beads containing immobilized p115 mass of these fragments was compared to their predicted mass without or with one additional phosphate was analyzed. As shown in Figure 2 , untreated GM130 bound to the p115 beads (lane 1), while GM130 treated group (corresponding to a mass increase of 80 Da). As a control, untreated N73pep was subjected to the same with mitotic cytosol, Cdk2-, or mock-depleted cytosol analysis. As shown in Figure 3B , only those fragments performing binding to p115 beads. As expected, binding of wild-type GM130 was inhibited by preincubation with containing Ser-25 had a mass consistent with the presence of one additional phosphate. This was true for the mitotic cytosol ( Figure 4B ). This was due to phosphorylation, since binding was not inhibited in the presence of V8 fragment (residues 20-45) containing both putative Cdc2 sites, showing the second site (Ser-43) to be unstaurosporine. Mutation of Ser-43 and/or Ser-82 had little effect upon the mitotic regulation of binding to p115 phosphorylated. With untreated N73pep, the mass of each peptide corresponded to that expected for no ( Figure 4B ). In contrast, mutation of Ser-25 in each of the constructs had a dramatic effect, GM130 now bindphosphorylation (not shown). We therefore conclude that Ser-25 represents the major mitotic phosphorylaing p115 under mitotic as well as interphase conditions. The level of binding of the Ser-25 mutants was similar tion site in GM130.
under both conditions, strongly suggesting that Ser-25 is the major residue involved in the mitotic regulation of Phosphorylation of GM130 on Serine 25 Inhibits Binding to p115 GM1130 binding to p115. To determine whether modification of Ser-25 can regulate binding to p115, it was mutated by site-directed mutagenesis to either mimic phosphorylation (Ser to
Mitotic Golgi Fragmentation Requires Cdc2
If Cdc2-mediated phosphorylation of GM130 is imporAsp) or prevent phosphorylation (Ser to Ala). The role of the two other putative Cdc2 sites (Ser-43 and Sertant for mitotic Golgi fragmentation, then Cdc2 should be required for this process. Previous experiments have 82) was also addressed by mutating these residues in the same manner. Wild-type and mutated constructs suggested a role for Cdc2 in mediating mitotic Golgi fragmentation in a cell-free system (Misteli and Warren, comprising the N-terminal half of GM130 were translated in vitro and their ability to bind p115 analyzed. Golgi 1994). This was achieved by adding cyclin A, which can bind and activate Cdk2 and Cdc2, to interphase cytosol membrane proteins were fractionated by SDS-PAGE, transferred to nitrocellulose, and overlaid with each of to generate a "pseudo-mitotic" cytosol. It was demonstrated that cyclin A was acting through Cdc2 and not the 35 S-labeled GM130 constructs. As seen previously , wild-type GM130 bound to two through Cdk2 to trigger Golgi disassembly. However, whether Cdc2 was acting directly or through other kiproteins of 130 kDa and 115 kDa, corresponding to GM130 and p115, respectively ( Figure 4A , lane 1). Mutanases activated downstream of Cdc2 could not be addressed in these experiments. We therefore performed tion of Ser-25 to Asp greatly reduced the binding to p115, while binding to GM130 was unaffected (Figure disassembly experiments using mitotic cytosol immunodepleted of Cdc2, which should contain the full com-4A, lane 3). Binding to p115 was not affected by any of the other mutations. plement of mitotically active kinases (except Cdc2), including kinases activated downstream of Cdc2 itself. We next studied binding of the GM130 mutants to p115 under interphase and mitotic conditions. The three Importantly, no Cdc2 could be detected on our purified Golgi membranes (not shown). Cisternal fragmentation putative Cdc2 sites were mutated to Ala separately or in combination and the corresponding mutant proteins was defined by the loss of cisternal membranes, with fragmentation induced by mitotic cytosol set to 100% preincubated with interphase or mitotic cytosol before Golgi membranes were incubated for 30 min either in buffer alone on ice (none) or at 37ЊC with interphase, mitotic, mock-depleted or Cdc2-depleted mitotic cytosol, or Cdc2-depleted mitotic cytosol plus purified cyclin B1-Cdc2 (added to same histone kinase activity as the mock-depleted sample). Membranes were then fixed, processed, and the percentage membrane in cisternae calculated. Results are presented as percentage of cisternal fragmentation Ϯ SEM (n ϭ 3-5), where 0% represents starting Golgi membranes (None, 48.8% Ϯ 3% in cisternal membranes) and 100% represents Golgi membranes after incubation with mitotic cytosol (25.3% Ϯ 2% in cisternal membranes).
of Cdc2 to bring about disassembly. Since this was at variance with our findings, we decided to investigate the role of MEK1 in Golgi fragmentation using our cellfree assay. We first analyzed the amount of MEK1 in the Cdc2-depleted cytosol. As shown in Figure 6A , MEK1 was present at a similar level in Cdc2-depleted cytosol to that present in mitotic and mock-depleted cytosol. The activity of MEK1 in the Cdc2-depleted cytosol was to 40 min had no effect upon the MEK1 activity, showing (B) 35 S-labeled GM130 constructs with the indicated Ser to Ala mutathat Cdc2 was not required to maintain MEK1 in the tions were incubated with interphase (I), mitotic (M), or mitotic cytosol inactivated with staurosporine (MϩSt). After addition of staurocytosol in an active state (not shown). We also measured sporine and microcystin to prevent any further changes in the MEK1 activity in our interphase and mitotic HeLa phosphorylation, p115 beads were added. Bound proteins were cytosols. As shown in Figure 6B , MEK1 is 2.5-fold less resolved by SDS-PAGE and detected by fluorography.
active in mitotic compared to interphase cytosol. Mitotic NRK extracts also had lower MEK1 activity compared to interphase extracts (not shown). These data already ( Figure 5 ). Depletion of Cdc2 reduced cisternal fragmensuggested that MEK1 was not required for mitotic Golgi tation to 35%, similar to the level observed for interphase fragmentation in our cell-free assay. To examine this cytosol (33% fragmentation), while mock depletion had more directly, mitotic cytosol was depleted of MEK1 no significant effect (95% fragmentation) ( Figure 5 ). Adusing specific antibodies. Immunoblotting confirmed dition of purified cyclin B1-Cdc2 to the Cdc2-depleted that more than 95% of MEK1 was removed ( Figure 6A , cytosol restored fragmentation to a level similar to milane 3). There was no detectable MEK1 on the purified totic cytosol (93%), showing that loss of fragmentation Golgi membranes ( Figure 6A , lane 6). When tested in was due to removal of Cdc2 and not some other compothe cell-free Golgi disassembly assay, MEK1-depleted nent of the cytosol. Mitotic Golgi fragmentation in vitro cytosol could fragment Golgi membranes to the same is therefore dependent upon active Cdc2 in the cytosol, extent as mock-depleted and mitotic cytosol (Figure even though other mitotically active kinases are present. 6D). The disassembly assay was also carried out using Cdc2-depleted cytosol supplemented with exogenous MEK1 Is Not Required for Mitotic Golgi activated MEK1 (added at three times the endogenous Fragmentation In Vitro level). Analysis of MEK1 activity confirmed that the exogIt has recently been reported that mitotic Golgi fragmenenous MEK1 was not inactivated in the assay (not tation requires MEK1 rather than Cdc2 (Acharya et al., shown). Addition of active MEK1 had no effect upon Golgi fragmentation ( Figure 6D ). 1998). It was proposed that MEK1 functions downstream To further investigate the role of MEK1 in Golgi frag-MEK1 also had no discernible effect upon total Golgi mentation, mitotic cytosol was pretreated with the highly protein phosphorylation. The pattern and amount of specific MEK1 inhibitor PD98059 (Alessi et al., 1995;  phosphorylation of Golgi proteins obtained using MEK1-Dudley et al., 1995) . This drug blocks the activation of depleted cytosol was indistinguishable from that ob-MEK1 by Raf or MEKK and can also directly inhibit lower tained with mock-depleted cytosol (not shown). activity forms of the kinase. Pretreatment of mitotic cytosol for up to 40 min with 50 M PD had no effect on MEK1 Is Not Required for Mitotic Golgi MEK1 activity, showing that MEK1 was not being inactiFragmentation In Vivo vated and reactivated in the cytosol (not shown). How-MEK1 is not required for mitotic Golgi fragmentation in ever, when PD was present during the MEK1 assay, it our cell-free assay, while it was required for mitotic fragsignificantly decreased MEK1 activity ( Figure 6C ), showmentation in the permeabilized cell system of Acharya ing it could directly inhibit the MEK1 in mitotic cytosol. et al. (1998) . To address this discrepancy and find out PD-treated mitotic cytosol was tested for its ability to which assay reflects the situation in vivo, we decided fragment Golgi membranes. Treatment of cytosol with to investigate whether MEK1 is required for mitotic Golgi up to 50 M PD had no effect upon mitotic Golgi fragfragmentation in intact cells. mentation ( Figure 6D ). Together these data indicate that
To study the role of MEK1 in mitotic Golgi fragmenta-MEK1 is not required for mitotic Golgi fragmentation in tion in vivo, we took advantage of the fact that PD98059 vitro.
can inhibit MEK1 in intact cells (Alessi et al., 1995; We also studied the effects of PD, MEK depletion, et al., 1995) . NRK cells were arrested in S phase using and active MEK upon phosphorylation of Golgi proteins aphidicolin, released from the block, and either left unand in particular GM130. Addition of PD or depletion of treated or incubated with 50 M PD for an additional 4 endogenous MEK1 from mitotic cytosol had no effect hr to allow the cells to progress into mitosis. Cells were upon the in vitro phosphorylation of GM130, and addilysed at 1 hr intervals during this time and the activity tion of active MEK1 to Golgi membranes did not stimulate GM130 phosphorylation ( Figure 6E ). Depletion of of MEK1 assessed by immunoblotting with an antibody specific for the phosphorylated forms of ERK1 and -2, into mitosis (not shown). PD had no effect upon mitotic Golgi fragmentation. Ninety-eight percent of PD-treated the two known MEK1 substrates. As shown in Figure  7A , PD abolished the phosphorylation of ERK1 and -2, metaphase cells had a fragmented Golgi, compared to 99% of control metaphase cells (n ϭ 100 cells). Golgi showing that PD inactivated MEK1 in vivo. Golgi fragmentation was studied in the PD-treated cells by immufragmentation in PD-treated cells was also studied by electron microscopy ( Figure 7D ). PD treatment had no nofluorescence microscopy using antibodies to the Golgi-marker GM130. Mitotic cells were identified using significant effect upon the number of mitotic Golgi clusters per cell, nor upon the average volume density (V D ) the DNA-specific dye Hoechst 33342 and the number of metaphase cells with a fragmented Golgi scored (see of the clusters. The average number of Golgi clusters per cell section was 6.1 Ϯ 3.1 for PD-treated cells, com- Figure 7C ). PD had no effect upon the number of cells entering mitosis ( Figure 7A ), demonstrating that MEK1 pared to 6.3 Ϯ 3.4 for untreated cells. The average V D of mitotic Golgi clusters from untreated cells was 0.0016 Ϯ is not required for mitotic entry. In contrast, the CDK inhibitor roscovitine (Meijer et al., 1997 ) blocked entry 0.001 and from PD-treated cells was 0.0017 Ϯ 0.001.
The role of MEK1 in vivo was examined further using abolish phosphorylation restored binding under mitotic conditions. Mutation of the other two putative Cdc2 sites anthrax toxin, which has recently been demonstrated (Ser-43 and Ser-82) had no discernible effect upon p115 to proteolytically inactivate MEK1 in intact cells (Duesbinding. These data are consistent with competitive bery et al., 1998). Cells released from an S phase arrest binding experiments that have localized the p115-bindwere either left untreated or incubated with anthrax toxin ing site to the first 40 amino acids of GM130 (not shown). for a further 4 hr to allow entry into mitosis. Cleavage This region is extremely well conserved between rat and of MEK1, which results in removal of the N-terminal human GM130 (93% identity compared to only 38% seven residues, was monitored by immunoblotting with identity for the next 40 amino acids downstream). Serantibodies to the N and C termini of MEK1. As shown 25 therefore resides in a highly conserved region of in Figure 7B , anthrax efficiently cleaved MEK1 after 2 GM130 that constitutes the minimally defined p115-hr, resulting in loss of reactivity to the N-terminal antibinding site, while the other two putative Cdc2 sites lie bodies. Probing with antibodies to the C terminus of outside this region. In addition, Ser-25 and its immediate MEK1 revealed an increased mobility and reduced levflanking residues are 100% conserved between rat and els of antigen after cleavage, as previously observed human, while Ser-43 and Ser-82 are not. These findings (Duesbery et al., 1998) . Immunoblotting with antibodies support the conclusion that Ser-25 alone regulates bindagainst phosphorylated ERK1 and -2 showed that MEK1 ing to p115. Further comparison of rat and human was inactivated in cells by the anthrax toxin-mediated GM130 revealed that the human sequence has two pocleavage ( Figure 7B ) as expected. Golgi fragmentation tential Cdc2 sites not present in the rat sequence (Serin anthrax toxin-treated cells was studied by immunoflu-53 and Thr-57). Whether these residues, both located orescence and electron microscopy (see Figures 7C and outside the p115-binding site, can be mitotically phos-7D). Inactivation of MEK1 by anthrax toxin had no effect phorylated and play a role in regulating binding to p115 upon mitotic entry ( Figure 7B ), nor upon mitotic Golgi must await further experiments. fragmentation. One hundred percent of anthrax toxinMany of the putative physiological substrates of Cdc2 treated metaphase cells had a fragmented Golgi, comare involved in maintaining organellar and cellular archipared to 99% of control metaphase cells (n ϭ 100 cells).
tecture (e.g., lamins of the nuclear matrix, vimentin on The average V D of mitotic Golgi clusters from untreated intermediate filaments) (see Nigg, 1995) . GM130 is the cells was 0.0024 Ϯ 0.0019 and from anthrax toxinfirst Golgi protein to be identified as a substrate for treated cells was 0.0024 Ϯ 0.0014. Together, the experiCdc2. Cdc2-mediated phosphorylation of GM130 is ments with PD and anthrax toxin demonstrate that MEK1
probably an important step in the mitotic fragmentation is not required for mitotic Golgi fragmentation in vivo, of the Golgi complex. It is one of the most highly phosconsistent with the results from our in vitro system. phorylated Golgi proteins in mitosis (Barr et al., 1997;  data not shown). Phosphorylation inhibits binding to the vesicle-docking protein p115, and this has been Discussion proposed to prevent docking of COPI vesicles with Golgi cisternae, leading to the cessation of membrane transSeveral lines of evidence strongly suggest that GM130 port and ultimately the COPI-mediated pathway of fragis a physiological substrate for Cdc2. First, depletion of mentation, the major mitotic Golgi fragmentation pathCdc2 from mitotic cytosol almost completely abolished way in vitro Nakamura et al., phosphorylation of a synthetic peptide corresponding 1997) . A reasonable model is therefore that phosphoryto the N-terminal 73 amino acids of GM130 as well as lation of Ser-25 by Cdc2 initiates the sequence of events phosphorylation of the native, full-length protein. Phosleading to the COPI pathway of mitotic Golgi fragmenphorylation was restored when purified cyclin B-Cdc2 tation. was added back to the same level as mitotic cytosol,
The other mitotic fragmentation pathway does not arguing against the possibility that another GM130 involve COPI. Cisternae become unstacked and the core kinase was somehow inactivated or depleted by the region appears to break down to form tubular networks anti-Cdc2 antibody coupled beads. Second, purified rethat fragment further, yielding heterogenous tubules and combinant cyclin B-Cdc2 phosphorylated the GM130 vesicles larger in size than COPI vesicles (Misteli and peptide and native, full-length GM130 to a similar extent Warren, 1995b) . Cdc2 is also involved in this pathway, as mitotic cytosol, while the related Cdk2 kinase did not.
since unstacking was also inhibited when mitotic cytosol Third, GM130 was phosphorylated by cyclin B-Cdc2 at was depleted of Cdc2 (not shown). That is not to say, the same site in vitro as that phosphorylated in vivo.
however, that Cdc2 is the only kinase involved in mitotic Fourth, GM130 is phosphorylated only in mitosis when Golgi fragmentation. It is possible that another kinase cyclin B-Cdc2 is active. Although we cannot entirely tightly associated with Golgi membranes is activated exclude the possibility that another, perhaps related, by Cdc2 and plays some role in fragmentation. Other kinase might carry out the GM130 phosphorylation in kinases could also be involved in aspects of the fragvivo, the combined data strongly suggest that Cdc2 is mentation process that occur in vivo that we have failed the GM130 kinase.
to reconstitute in the cell-free assay. For example, the Ser-25 was identified as the major GM130 mitotic earliest event of fragmentation in vivo, the breakdown phosphorylation site using a combination of peptide of the Golgi ribbon to form discrete stacks, is not remapping and mass spectrometry. The importance of constituted in our cell-free assay, which starts with the Ser-25 in regulating binding to p115 was confirmed by discrete stacks themselves. Another kinase might be mutational analysis. Mutation of Ser-25 to mimic phosinvolved in this or perhaps other steps in vivo. Interestingly, it has recently been reported that MEK1 is phorylation inhibited binding to p115, while mutation to , and N terminus of MEK1 (662; kindly the kinase responsible for mitotic Golgi fragmentation provided by Dr. J. Ferrell) . Activated MEK1 and recombinant ERK2 (Acharya et al., 1998 Golgi-associated ERK to bring about fragmentation. This was discovered using a morphological assay based Immunodepletion of Kinases from Mitotic Cytosol upon addition of mitotic cytosol to permeabilized cells.
Mitotic HeLa cytosol (Stuart et al., 1993) was desalted into buffer A (20 mM ␤-glycerophosphate, 15 mM EGTA, 50 mM KOAc, 10 mM Fragmentation was observed by immunofluorescence MgOAc, 2 mM ATP, 1mM DTT). Three hundred microliters of cytosol staining of a Golgi marker, which changed from a perinu-(10-12 mg/ml) was incubated with antibody-coupled beads (45 g clear ribbon into many small punctate structures scatantibodies against Cdc2, Cdk2, or MEK1 [C-18] on 50 l protein tered throughout the cell (Acharya et al., 1998) . Frag-A-sepharose) for 1 hr at 4ЊC, the beads removed by centrifugation, mentation occurred in the absence of Cdc2, while and another 50 l beads added for an additional 1 hr at 4ЊC. The addition of the MEK1-inhibitor PD or depletion of MEK1 beads were removed and the supernatants stored at Ϫ80ЊC. from cytosol was found to inhibit the process (Acharya et Production and Purification of CDKs al., 1998). However, no electron microscopical evidence Cyclins and CDKs were coexpressed in baculovirus-infected cells was provided that the scattered Golgi structures were as described previously (Krude et al., 1997). true mitotic clusters. This is particularly important, since at the level of immunofluorescence microscopy it is imHistone Kinase Assay possible to distinguish Golgi stacks from Golgi clusters One microliter of sample was added to 10 l buffer A containing 2 mg/ml histone H1 and 0.1 Ci/l [␥-32 P]ATP and incubated for 30 (Shima et al., 1997) , and it is therefore unclear if a genumin at 30ЊC. Five microliters was spotted onto P81 paper (Whatman) ine mitotic fragmentation process was being analyzed.
and washed four times with 150 mM phosphoric acid and once Using our cell-free mitotic fragmentation assay based with 95% ethanol. After drying, samples were subjected to liquid upon electron microscopical analyses of the conversion scintillation counting.
of Golgi cisternae to small vesicles and tubules , we could find no evidence of a reIn Vitro Phosphorylations quirement for MEK1. Inhibition of MEK1 with PD, depleN73pep, in vitro-synthesized GM130, or salt-washed Golgi membranes (Levine et al., 1996) were incubated in buffer A with mitotic tion of MEK1, or addition of active MEK1 had no effect cytosol (2-10 mg/ml) or purified kinase for 10-30 min at 30ЊC. In upon GM130 phosphorylation or Golgi fragmentation. somatic cells during mitosis due to phosphorylation by and binding of GM130 to p115 beads were performed as described Cdc2 (Rossomando et al., 1994) and agrees well with .
studies from a number of labs demonstrating low ERK activity in mitotic somatic cells (Heider et al., 1994; Edel- Cell Culture, Drug Treatments, and Lysate Preparation mann et al., 1996; Takenaka et al., 1998) . The low MEK1
For enrichment of mitotic NRK cells, 2.5 g/ml aphidicolin was activity in mitosis is consistent with MEK1 not being a added to the medium for 14 hr and the cells released from the S phase block by washing into fresh medium. One hour after release, key mitotic regulator of Golgi fragmentation. added to cells to inactivate MEK1, and mitotic Golgi glycerol, 0.5% Triton X-100, 5 mM EDTA, 2 mM EGTA, 10 mM NaF, fragmentation was then studied. PD did inhibit MEK1 40 mM ␤-glycerophosphate, 1 mM sodium orthovanadate, 1 mM DTT) containing PI. After 10 min at 4ЊC, lysates were clarified by activity but had no effect upon mitotic Golgi fragmentacentrifugation and stored at Ϫ80ЊC.
tion at the level of both immunofluorescence and electron microscopy. To eliminate completely the possibility vivo by anthrax toxin (Duesbery et al., 1998) . Treatment before incubation with 25 l kinase buffer containing 0.5 g ERK2 of cells with anthrax toxin cleaved all of the cellular (in the presence or absence of PD) for 30 min at 30ЊC. The beads MEK1 but had no effect upon mitotic Golgi fragmentawere removed by centrifugation and 10 l of the supernatant incution. Taking all the data together, we conclude that mibated with 10 l kinase buffer containing 10 g MBP and 1 Ci/l totic Golgi fragmentation is dependent upon Cdc2 and [␥-32 P]ATP for another 30 min at 30ЊC. Five microliters was spotted independent of MEK1.
onto P81 paper and processed for liquid scintillation counting.
Immunofluorescence and Electron Microscopy Experimental Procedures of Drug-Treated Mitotic Cells
Cells were fixed and stained for immunofluorescence microscopy Reagents and Antibodies as described (Shima et al., 1997) . For electron microscopy, mitotic The following antibodies were used: phosphorylated ERK (New England Biolabs), Cdk2 and Cdc2 (Upstate Biotech.), C terminus of cells were flushed from the dish, fixed in 2% gluteraldehyde in PBS
